Times Online

Obama Budget Would Create 4 Billion Health-Care FundWashington PostBy Ceci Connolly President Obama intends to release a budget tomorrow that creates a 10-year, 4 billion "reserve fund" to partially pay for a vast expansion of the US health care system, an overhaul that many experts project will cost as much as …Video: [...]

TheMedGuru

European Commission Approves EFIENT(R) (prasugrel) for Patients …FOXBusinessDaiichi Sankyo Company, Limited (TSE: 4568) and Eli Lilly and Company (NYSE: LLY) announced today that the European Commission has granted marketing authorization for EFIENT(R) (prasugrel) for the prevention of atherothrombotic events in patients with …Lilly and Daiichi win European approval for blood thinner drug Trading [...]

Merck Tells Of 'Tortured Path' In Making Asthma DrugCNNMoney.comBy Peter Loftus and Thomas Gryta TRENTON, NJ -(Dow Jones)- Merck & Co. (MRK) took a "tortured path" in developing its blockbuster asthma and allergy drug Singulair, a lawyer for the company told a judge Monday in an effort to ward off early generic …Merck seeks to [...]

UK biotech raises mln from Novartis, othersReutersLONDON, Feb 24 (Reuters) - Heptares Therapeutics Ltd, a two-year-old British biotech company, has raised 21 million pounds (.6 million) in private equity finance from Novartis (NOVN.VX) and two venture capital firms, it said on Tuesday. …Heptares Secures GBP21 Million in Series A Fund Raising to … FOXBusinessall [...]

Pfizer axes two drug development programsMarketWatch"The decision to terminate these programs will enable the business unit to allocate additional resources to higher-potential development programs," said Pfizer in a statement. The decision was taken after the New York-based company decided that the …Pfizer cancels development of two late-stage drugs ReutersPfizer Drops Two Late-Stage Drugs, Putting [...]

Getting a share of false claimsCentre Daily Times, PAFor example, whistleblowers helped build the case against Eli Lilly & Co. for its illicit off-label marketing scheme surrounding the promotion of the prescription drug Zyprexa. Eli Lilly agreed to pay .4 billion to settle the case, which was brought …

Justice Roberts's PortfolioWashington Post, United StatesTHE PLANNED merger of pharmaceutical firms Pfizer Inc. and Wyeth has created a complication in one of the most important business cases before the Supreme Court this term. The case of Wyeth v. Levine was heard by the justices in November; …

Options Update: Bristol-Myers Squibb Calls Spike on Abbott Labs …Schaeffers Research, OHby Joseph Hargett (jhargett@sir-inc.com) 2/20/2009 1:30 PM Earlier today, pharmaceutical concern Bristol-Myers Squibb (BMY: sentiment, chart, options) settled a dispute with Abbott Laboratories (ABT: sentiment, chart, options) related to an alleged …BMS Settles Container Patent Suit Against Abbott IP Law360 (subscription)all 2 news articles

Merck & Co subsidiary to hire 300 people in IndiaTimes of India, IndiaUDAIPUR: MSD India, a wholly-owned subsidiary of US drug maker Merck & Co, plans to hire 300 people this year as it looks to expand its presence in the Indian market, where it intends to introduce more vaccines. The company plans to introduce [...]

Sanofi-Aventis and AZ Launch YouTube SitesPharmExec.com, NJSanofi-Aventis and AstraZeneca both launched YouTube sites to reach patients and consumers searching for information on the popular video content sharing site. The Sanofi channel is part of its integrated GoInsulin campaign, an unbranded health …Sanofi-Aventis US Launches Diabetes-Focused YouTube Channel PharmaLive.com (press release)Sanofi-Aventis joins YouTube revolution Pharmafocusall 3 news [...]